Officials are examining whether those affected have a genetic trait that leaves them at greater risk of side-effects from the ...

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a new study into GLP-1 medicines after worrying ...

Hundreds of people have reported problems with their pancreas after taking GLP-1 agonists, including ten deaths.

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

Orforglipron is an oral drug from Eli Lilly that’s in trial stage. The New York Times reports that in a trial of over 500 ...

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

All too often celebrities will tell a white lie when asked the secret to their new figure after drastic weight loss, but Amy ...

A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful ...

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.